FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Roblox CEO calls child predator crisis an ‘opportunity’ amid ban of gamer who exposed groomers on platform

Miami woman allegedly slices boyfriend with machete after restaurant fight over infidelity

‘Zizian’ ringleader accuses Trump admin of transgender ‘genocide’ in courtroom tirade

DHS says four House Democrats ‘chose to stand with criminal illegal aliens’ after visiting ICE detainee

Navy sailor dies after rescuing 2 children from high surf in Hawaii waters

Parents/Grandparents Alert: Christmas AI Teddy Bears Can Teach Kids About Bondage Sex, How to Light Matches, Where to Find Knives, Pills, Plastic Bags

Fact Check: Did the Trump Administration Declare Nurses Aren’t ‘Professionals’?

NYC Council welcomes new mayor with bill that would dramatically raise salaries for city officials

Taliban vows to respond after alleged Pakistani strikes rock Afghanistan overnight

Trump Admin to Begin ‘Comprehensive Review’ of Every Refugee Admitted to US Under Biden

Trump, Duffy slam Pritzker’s ‘soft-on-crime policies’ after Chicago woman set on fire on train

Missing Virginia high school coach investigated for child porn and soliciting a minor, police say

Fox News Politics Newsletter: Former Army captain warns Dems’ ‘unpatriotic’ video could spark chaos

‘World’s Strongest Woman’ Winner Disqualified After Being Found to Be a Man

Trump calls Chicago ‘out of control’ after train attack left woman critically burned

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”